Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR)

ClinicalTrials.gov ID: NCT06041269

Public ClinicalTrials.gov record NCT06041269. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 7:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis

Study identification

NCT ID
NCT06041269
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
AnaptysBio, Inc.
Industry
Enrollment
420 participants

Conditions and interventions

Interventions

  • Rosnilimab Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 30, 2023
Primary completion
Nov 28, 2024
Completion
May 29, 2025
Last update posted
Nov 24, 2024

2023 – 2025

United States locations

U.S. sites
36
U.S. states
12
U.S. cities
34
Facility City State ZIP Site status
AnaptysBio Investigative Site 10-132 Flagstaff Arizona 86001
AnaptysBio Investigative Site 10-130 Glendale Arizona 85306
AnaptysBio Investigative Site 10-129 Phoenix Arizona 85037
AnaptysBio Investigative Site 10-131 Tucson Arizona 85704
AnaptysBio Investigative Site 10-105 Covina California 91722
Anaptys Bio Investigative Site 10-119 Rancho Mirage California 92270
AnaptysBio Investigative Site 10-113 San Diego California 92108
AnaptysBio Investigative Site 10-127 San Francisco California 94123
AnaptysBio Investigative Site 10-136 Temecula California 92592
AnaptysBio Investigative Site 10-133 Upland California 91786
AnaptysBio Investigative Site 10-112 Whitter California 90602
AnaptysBio Investigative Site 10-103 Aventura Florida 33180
AnaptysBio Investigative Site 10-141 Avon Park Florida 33825
AnaptysBio Investigative Site 10-118 Boynton Beach Florida 33436
AnaptysBio Investigative Site 10-125 Daytona Beach Florida 32117
AnaptysBio Investigative Site 10-122 Homestead Florida 33032
Anaptys Bio Investigative Site 10-142 Miami Florida 33125
AnaptysBio Investigative Site 10-140 Miami Florida 33126
AnaptysBio Investigative Site 10-102 Miami Florida 33155
AnaptysBio Investigative Site 10-124 Plantation Florida 33324
AnaptysBio Investigative Site 10-139 West Palm Beach Florida 33407
AnaptysBio Investigative Site 10-114 Chicago Illinois 60640
AnaptysBio Investigative Site 10-145 Monroe Louisiana 71203
AnaptysBio Investigative Site 10-143 Brookline Massachusetts 02445
AnaptysBio Investigative Site 10-116 Albuquerque New Mexico 87102
AnaptysBio Investigative Site 10-148 Smithfield North Carolina 27577
AnaptysBio Investigative Site 10-146 Middleburg Heights Ohio 44130
AnaptysBio Investigative Site 10-101 Jackson Tennessee 38305
AnaptysBio Investigative Site 10-120 Allen Texas 75013
AnaptysBio Investigative Site 10-107 Colleyville Texas 76034
AnaptysBio Investigative Site 10-123 Katy Texas 77450
AnaptysBio Investigative Site 10-108 Mesquite Texas 75150
AnaptysBio Investigative Site 10-110 Plano Texas 75024
AnaptysBio Investigative Site 10-106 The Woodlands Texas 77382
AnaptysBio Investigative Site 10-121 Tomball Texas 77375
AnaptysBio Investigative Site 10-117 Beckley West Virginia 25801

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 56 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06041269, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 24, 2024 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06041269 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →